This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 18 and 65
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

To investigate the efficacy and safety of OPC-34712 in comparison with placebo in patients with schizophrenia.

Provided treatments

  • Drug: OPC-34712
  • Drug: OPC-34712
  • Drug: OPC-34712
  • Drug: Placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01451164. The sponsor of the trial is Otsuka Pharmaceutical Co., Ltd. and it is looking for 459 volunteers for the current phase.
Official trial title:
A Dose-finding Trial of OPC-34712 in Patients With Schizophrenia